Literature DB >> 30227328

MiR-545-3p/MT1M axis regulates cell proliferation, invasion and migration in hepatocellular carcinoma.

Liu Changjun1, Huang Feizhou2, Peng Dezhen3, Lei Zhao4, Mao Xianhai4.   

Abstract

Studies have shown that metallothionein 1 M (MT1M) is a tumor suppressor gene which is frequently down-regulated in human hepatocellular carcinoma (HCC). The methylation of MT1M promoter region is one of the important transcriptional regulation mechanisms that contribute to the loss of its expression. In our study, we found that there are still half of the 55 HCC tumor tissues in our cohort do not share the promoter methylation of MT1M. So, we speculated there maybe another mechanism participating in the downregulation of MT1M in HCC. Then, we provided evidences that miR-545-3p, which served as a tumor promoter, post-transcriptionally regulate MT1M in HCC through binding to its untranslated region (3'UTR). Taking together, we investigated the role of miR-545-3p in the process of HCC through regulating MT1M.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; Invasion and migration; MT1M; miR-545-3p

Mesh:

Substances:

Year:  2018        PMID: 30227328     DOI: 10.1016/j.biopha.2018.09.009

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  19 in total

1.  CircFGGY Inhibits Cell Growth, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma via Regulating the miR-545-3p/Smad7 Axis.

Authors:  Kun-Liang Feng; Na Diao; Zhai-Wen Zhou; Chong-Kai Fang; Ji-Nan Wang; Ying Zhang; Rui Luo; Chong Zhong
Journal:  Front Cell Dev Biol       Date:  2022-05-03

2.  Metallothionein MT1M Suppresses Carcinogenesis of Esophageal Carcinoma Cells through Inhibition of the Epithelial-Mesenchymal Transition and the SOD1/PI3K Axis.

Authors:  Dandan Li; Weiyan Peng; Bin Wu; Huan Liu; Ruizhen Zhang; Ruiqin Zhou; Lijun Yao; Lin Ye
Journal:  Mol Cells       Date:  2021-04-30       Impact factor: 5.034

3.  Long Noncoding RNASBF2-AS1 Promotes Gastric Cancer Progression via Regulating miR-545/EMS1 Axis.

Authors:  Mingyuan He; Li Feng; Lingzhi Qi; Min Rao; Yonggang Zhu
Journal:  Biomed Res Int       Date:  2020-06-12       Impact factor: 3.411

4.  SIRT1 inhibits hepatocellular carcinoma metastasis by promoting M1 macrophage polarization via NF-κB pathway.

Authors:  Bei Zhou; Yun Yang; Cuiping Li
Journal:  Onco Targets Ther       Date:  2019-04-04       Impact factor: 4.147

5.  CircABCC2 Regulates Hepatocellular Cancer Progression by Decoying MiR-665.

Authors:  Ning Bai; Eming Peng; Fada Xia; Dong Wang; Xiaogang Li; Xinying Li
Journal:  J Cancer       Date:  2019-06-10       Impact factor: 4.207

6.  LncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating miR-543-3p/SLC39A10/PTEN Axis in Prostate Cancer.

Authors:  Zhaohui Jia; Wensheng Li; Pan Bian; Hui Liu; Dong Pan; Zhongling Dou
Journal:  Onco Targets Ther       Date:  2020-09-22       Impact factor: 4.345

7.  C-X-C motif chemokine 16, modulated by microRNA-545, aggravates myocardial damage and affects the inflammatory responses in myocardial infarction.

Authors:  Fang-Qian Liang; Jing-Yuan Gao; Ji-Wei Liu
Journal:  Hum Genomics       Date:  2021-02-26       Impact factor: 4.639

8.  Circ_0072083 interference enhances growth-inhibiting effects of cisplatin in non-small-cell lung cancer cells via miR-545-3p/CBLL1 axis.

Authors:  Huiping Li; Fangfang Liu; Wenjing Qin
Journal:  Cancer Cell Int       Date:  2020-03-12       Impact factor: 5.722

9.  Long Noncoding RNA LINC01410 Suppresses Tumorigenesis and Enhances Radiosensitivity in Neuroblastoma Cells Through Regulating miR-545-3p/HK2 Axis.

Authors:  Liping Mou; Lili Wang; Shaoming Zhang; Qinghua Wang
Journal:  Onco Targets Ther       Date:  2021-05-18       Impact factor: 4.147

10.  Circular RNA Circ_0067934 Attenuates Ferroptosis of Thyroid Cancer Cells by miR-545-3p/SLC7A11 Signaling.

Authors:  Hui-Hui Wang; Jia-Ni Ma; Xiao-Rong Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-05       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.